McKesson and Independence Health provided the capital for healthcare marketplace Accolade, which previously received funding from investors including Comcast.

Oncology-focused biotechnology developer Immunocore has raised the largest ever funding round by a European private life sciences company.

The asthma and peanut allergy treatment company has now raised $89m in total, after closing a series D round backed by BioMed Realty and returning investor Novo.

Isis Innovation and Ludwig Cancer Research join forces on immunotherapy spinout iOx Therapeutics.

Merck Global Health Innovation Fund co-led the $5m equity portion of the series B round, while Silicon Valley Bank provided $3m in debt financing.

The GlaxoSmithKline spin-out, which is working on treatments for hearing disorders, has raised additional funds to extend the Pfizer-backed round to $36.6m.

Nuvelution, which is aiming to bring a collaborative element to drug development, has raised an undisclosed amount in a Novo-backed series A round.

The healthcare research services provider will contribute $50m of the capital as an anchor investor and seek to fund China and US-based portfolio companies.